Thursday, January 20, 2022 4:58:20 PM
Sir Pumpernickel,
Now, now Sir P you know the error of taking partial quotes out of context. “Judas hanged himself” “..go and do thou likewise” was an example I was given years ago. That first partial quote you referenced was about keeping patients from getting their hopes up about a treatment that could not yet be made available and that Linda is concerned about this aspect of product development not that she is hiding from anyone.
The second quote is about increased dedicated space for a vaccine candidate and a specific type of virus vector that just so happens to be in a line utilized by hmmm. Oh and the rooms are being fitted out with additional equipment to increase output hmmm. By the way, this announcement came Q4 of 2021 which is probably a little late for introduction as a Covid vaccine candidate especially when antiviral pills are being approved and boosters are already being given.
Praying for your safety with that work. Blessings and best wishes.
Now, now Sir P you know the error of taking partial quotes out of context. “Judas hanged himself” “..go and do thou likewise” was an example I was given years ago. That first partial quote you referenced was about keeping patients from getting their hopes up about a treatment that could not yet be made available and that Linda is concerned about this aspect of product development not that she is hiding from anyone.
The second quote is about increased dedicated space for a vaccine candidate and a specific type of virus vector that just so happens to be in a line utilized by hmmm. Oh and the rooms are being fitted out with additional equipment to increase output hmmm. By the way, this announcement came Q4 of 2021 which is probably a little late for introduction as a Covid vaccine candidate especially when antiviral pills are being approved and boosters are already being given.
Praying for your safety with that work. Blessings and best wishes.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
